雙林股份(300100.SZ):自主研發的反向式行星滾柱絲槓產品,爲國產機器人“關節”技術的自主化發展提供了強有力的支持
格隆匯3月18日丨雙林股份(300100.SZ)在投資者互動平臺表示,公司自主研發的反向式行星滾柱絲槓產品,具備“高負載、高精度、長壽命”的核心優勢,能夠在大幅提升負載能力、轉速及壽命的同時,降低量產成本,爲國產機器人“關節”技術的自主化發展提供了強有力的支持。此外公司還通過收購無錫科之鑫機械科技有限公司,進一步整合“材料-設計-加工-檢測”全產業鏈能力,其高精度磨削技術可大大提升產品一致性及良率,縮短研發週期,使得公司成爲全球先進的掌握反向式絲槓四大核心工藝的企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.